SEEGENE, INC.
Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.
As of 2026-10-10, SEEGENE, INC. has 202 Korean MFDS device approvals, 287 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2000 and listed on KOSDAQ in 2010, Seegene is a molecular diagnostics reagent company built on its Syndromic qPCR technology. It offers reagents such as the Allplex™ Respiratory Panel for respiratory infections, the Allplex™ STI Essential Assay for sexually transmitted infections, and the Allplex™ GI-Bacteria assay for gastrointestinal infections, based on its proprietary DPO™, TOCE™, and MuDT™ technologies and a 3Ct technology that integrates 19 patents. It has obtained approvals for a total of 121 products across countries worldwide, holds patents covering 35 core technologies, and sells through local subsidiaries in nine countries (Italy, UAE, US, Canada, Germany, Brazil, Mexico, Colombia, and South Africa) and distributors in more than 100 countries, with exports accounting for 91% of revenue as of 2024.
Products & technology
- Allplex™ Respiratory Panel (1A/2/3), Allplex™ RV Master Assay, Allplex™ PneumoBacter AssayDiagnosis of respiratory viral and bacterial infections
- Allplex™ STI Essential Assay, Allplex™ CT/NG/MG/TV Assay, and othersDiagnosis of sexually transmitted infections including chlamydia, gonorrhea, and trichomoniasis
- Allplex™ GI-Virus, GI-Bacteria, GI-Parasite, GI-Helminth AssayDiagnosis of gastrointestinal infections such as norovirus and rotavirus
- Human papillomavirus (HPV) diagnostic productsTesting for high- and low-risk HPV strains associated with cervical cancer
Regulatory approvals
data.go.kr202 Korean MFDS device approvals · 2008–2026
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2026-09-10Product approval · Class 3체외 제허 26-695 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2026-09-10Product approval · Class 3체외 제허 26-694 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2026-09-10Product approval · Class 3체외 제허 26-693 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2026-09-10Product approval · Class 3체외 제허 26-692 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2026-09-10Product approval · Class 3체외 제허 26-691 호
- MFDSIVD reagents for extracting nucleic acids2026-02-26Product approval · Class 1체외 제신 26-255 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2026-02-25Product approval · Class 3체외 제허 26-155 호
- MFDSIVD reagents for Infectious disease marker(Drug resistant microorganism)2026-02-25Product approval · Class 3체외 제허 26-154 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2024-12-23Product approval · Class 3체외 제허 24-896 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2024-11-25Product approval · Class 3체외 제허 24-830 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2024-06-26Product approval · Class 3체외 제허 24-426 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2024-06-19Product approval · Class 3체외 제허 24-407 호
Show 68 more
- MFDSIVD reagents for extracting nucleic acids2022-11-28Product approval · Class 1체외 제신 22-1675 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-05-31Product approval · Class 3체외 제허 22-355 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-05-31Product approval · Class 3체외 제허 22-354 호
- MFDSIVD reagents for extracting nucleic acids2022-05-30Product approval · Class 1체외 제신 22-754 호
- MFDSIVD reagents for extracting nucleic acids2022-05-30Product approval · Class 1체외 제신 22-752 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-05-24Product approval · Class 3체외 제허 22-333 호
- MFDSIVD reagents for extracting nucleic acids2022-05-23Product approval · Class 1체외 제신 22-725 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-05-19Product approval · Class 3체외 제허 22-321 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-02-28Product approval · Class 3체외 제허 22-138 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-12-20Product approval · Class 3체외 제허 21-1024 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-12-13Product approval · Class 3체외 제허 21-1000 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-11-29Product approval · Class 3체외 제허 21-958 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-06-30Product approval · Class 3체외 제허 21-537 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-04-12Product approval · Class 3체외 제허 21-284 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-04-12Product approval · Class 3체외 제허 21-283 호
- MFDSIVD reagents for extracting nucleic acids2021-04-07Product approval · Class 1체외 제신 21-467 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-03-04Product approval · Class 3체외 제허 21-164 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-01-26Product approval · Class 3체외 제허 21-65 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-12-07Product approval · Class 3체외 제허 20-1049 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-12-07Product approval · Class 3체외 제허 20-1051 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-11-30Product approval · Class 3체외 제허 20-1005 호
- MFDSIVD reagents for extracting nucleic acids2020-11-18Product approval · Class 1체외 제신 20-1669 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-10-19Product approval · Class 3체외 제허 20-895 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-09-28Product approval · Class 3체외 제허 20-845 호
- MFDSIVD reagents for extracting nucleic acids2020-07-07Product approval · Class 1체외 제신 20-1035 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-04-28Product approval · Class 3체외 제허 20-335 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-02-17Product approval · Class 3체외 제허 20-119 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-02-13Product approval · Class 3체외 제허 20-117 호
- MFDSIVD reagents for Infectious disease marker(Drug resistant microorganism)2019-12-27Product approval · Class 3체외 제허 19-842 호
- MFDSIVD reagents for extracting nucleic acids2019-11-04Product approval · Class 1체외 제신 19-1428 호
- MFDSIVD reagents for extracting nucleic acids2019-10-31Product approval · Class 1체외 제신 19-1414 호
- MFDSIVD reagents for extracting nucleic acids2019-10-31Product approval · Class 1체외 제신 19-1415 호
- MFDSExtractor, nucleic acid2019-10-14Product approval · Class 1체외 제신 19-1342 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2019-06-13Product approval · Class 3체외 제허 19-367 호
- MFDSExtractor, nucleic acid2019-05-10Product approval · Class 1체외 제신 19-594 호
- MFDSExtractor, nucleic acid2019-05-09Product approval · Class 1체외 제신 19-591 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2019-02-14Product approval · Class 3체외 제허 19-97 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2019-02-12Product approval · Class 3체외 제허 19-93 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2019-01-22Product approval · Class 3체외 제허 19-59 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2019-01-22Product approval · Class 3체외 제허 19-58 호
- MFDSIVD reagents for Infectious disease marker(Drug resistant microorganism)2019-01-22Product approval · Class 3체외 제허 19-57 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-12-11Product approval · Class 3체외 제허 18-792 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-12-11Product approval · Class 3체외 제허 18-791 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-12-11Product approval · Class 3체외 제허 18-790 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-12-03Product approval · Class 3체외 제허 18-768 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-11-28Product approval · Class 3체외 제허 18-759 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-07-24Product approval · Class 3체외 제허 18-520 호
- MFDSIVD reagents for extracting nucleic acids2018-07-16Product approval · Class 1체외 제신 18-855 호
- MFDSIVD reagents for extracting nucleic acids2018-07-16Product approval · Class 1체외 제신 18-860 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-20Product approval · Class 3체외 제허 18-436 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-20Product approval · Class 3체외 제허 18-435 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-20Product approval · Class 3체외 제허 18-434 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-20Product approval · Class 3체외 제허 18-433 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-19Product approval · Class 3체외 제허 18-426 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-19Product approval · Class 3체외 제허 18-425 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-19Product approval · Class 3체외 제허 18-424 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-19Product approval · Class 3체외 제허 18-423 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-19Product approval · Class 3체외 제허 18-422 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-06-12Product approval · Class 3체외 제허 18-409 호
- MFDSIVD reagents for extracting nucleic acids2018-06-11Product approval · Class 1체외 제신 18-715 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-05-30Product approval · Class 3체외 제허 18-384 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-05-16Product approval · Class 3체외 제허 18-361 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-05-11Product approval · Class 3체외 제허 18-341 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-05-11Product approval · Class 3체외 제허 18-340 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-05-04Product approval · Class 3체외 제허 18-329 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-05-04Product approval · Class 3체외 제허 18-328 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-05-02Product approval · Class 3체외 제허 18-320 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2018-04-19Product approval · Class 3체외 제허 18-275 호
Showing the 80 most recent of 202 records.
R&D and key agreements
Source: DART corporate disclosure신드로믹 정량 PCR(Syndromic qPCR) 및 3Ct 기술 · Holds proprietary DPO™, TOCE™, and MuDT™ technologies and completed 3Ct technology integrating 19 patents to simultaneously test 15 targets and provide quantitative Ct values in a single assay
SGDDS(Seegene Digitalized Development System) · Building an automated reagent development system toward realizing SG OneSystem™
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- A multicenter consensus-based value set for specimen containers mapped to SNOMED CT: development and external validation.
International journal of medical informatics · 2026-11 · Ryu H, Park K, Sung S 외 7
- Direct Oral Anticoagulant-Calibrated Heparin LRT Assay as a Rapid Alternative to an Anti-Factor Xa Assay for Measuring Apixaban, Edoxaban, and Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation.
International journal of laboratory hematology · 2026-10 · Woo KS, Kim DH, Park JS 외 2
- Postmortem Demonstration of Tau Pathology in a Korean Patient With WDR45-Related β-Propeller Protein-Associated Neurodegeneration.
Journal of clinical neurology (Seoul, Korea) · 2026-09 · Sohn JE, Lee K, Kim Y 외 1
- Essential Data Elements for Laboratory Test Interoperability: An Expert Consensus-Based Framework.
Annals of laboratory medicine · 2026-09 · Kim HN, Kim MS, Kim S 외 26
- The impact of lymph node harvest on recurrence in rectal cancer after neoadjuvant chemoradiotherapy.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2026-08 · Jo MH, Kim DW, Lee JA 외 11
- Comprehensive and reproducible grading of the Updated Sydney System in gastric biopsies using artificial intelligence: multi-pathologist validation and a reader study.
Histopathology · 2026-08 · Kim HH, Jeong WC, Hwang Y 외 3
- Clinical Impact of Discordant Minimal Residual Disease Assessment in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplantation and cellular therapy · 2026-07 · Yoon JH, Jung J, Lee S 외 5
- Comparative detection of respiratory pathogens in pediatric and adult patients using a multiplex panel.
Medicine · 2026-07 · Kim YJ, Jang WS, Park S 외 4
- GAFAD: A liquid chromatography-tandem mass spectrometry-based model for early hepatocellular carcinoma detection beyond GALAD's limitations.
Clinical and molecular hepatology · 2026-07 · Kim H, Oh W, Park J 외 5
- Patient-specific lung cancer tumoroids recapitulate the tumor microenvironments for functional evaluation of therapeutic responses and immune-stromal interactions.
Journal of translational medicine · 2026-06 · Ko YR, Park CW, Kim J 외 7
Show 277 more publications
- Integrated multiomics reveals starvation-driven keratin degradation and persistence in Fervidobacterium islandicum AW-1.
iScience · 2026-05 · Sung JY, Kim JY, Jin HS 외 8
- Unique TTR Variants D38A and M13dup Among Korean Patients with Hereditary Transthyretin Amyloidosis: A Retrospective Single-Center Cohort Study.
Annals of laboratory medicine · 2026-05 · Park MS, Lee JJ, Kim D 외 6
- Large Language Models' Performances regarding logical observation identifiers names and codes mapping in laboratory medicine: A comparative analysis of ChatGPT-4.0, Gemini, and Perplexity.
International journal of medical informatics · 2026-04 · Yu S, Cho EJ, Kim S 외 4
- Clade Differentiation of Candida auris (Candidozyma auris) Clinical Isolates from Korean Hospitals Using Multilocus Sequence Typing and Sequence-Based Identification.
Annals of laboratory medicine · 2026-04 · Kwon YJ, Byun SA, Jeong SH 외 11
- Tumor-Associated Macrophage Infiltration and PD-L1 Expression in Gastric Cancer According to a Modified TCGA-Based Classification.
Journal of gastric cancer · 2026-04 · Song B, Koo DH, Kim EJ 외 9
- Is Complete Mesocolic Excision with Central Vascular Ligation Necessary for Suspected Early-stage Right-sided Colon Cancer?
Cancer research and treatment · 2026-04 · Choi MJ, Kim DW, Jun YK 외 5
- Receptor-Free Cellular Internalization of DNA Micelles Driven by Membrane Interaction.
ACS nano · 2026-04 · Kim H, Lee J, Jeon E 외 13
- Prevalence and Distribution of Antimicrobial Resistance-Associated Mutations in Mycoplasma genitalium Identified Through Routine Molecular Diagnostics in Korea.
Microorganisms · 2026-03 · Lim HJ, Hong YT, Baek SH 외 4
- High-Grade Astrocytoma With Piloid Features: An Aggressive Clinicogenomic Entity Distinct From Pilocytic Astrocytoma.
Journal of Korean medical science · 2026-03 · Kang J, Kim EE, Lee K 외 8
- Ranking-Aware Multiple Instance Learning for Histopathology Slide Classification: Development and Validation Study.
JMIR medical informatics · 2026-02 · Kim HH, Hwang G, Jeong WC 외 1
- Impact of estrogen receptor expression levels on chemo-responsiveness and prognosis of breast cancer patients treated with neoadjuvant chemotherapy.
NPJ breast cancer · 2026-02 · Bai K, Sung HJ, Chung YR 외 7
- Prevalence and genotype distribution of human papillomavirus among Korean males: Implications for vaccination strategies.
Investigative and clinical urology · 2026-01 · Jo SB, Ahn ST, Kim JW 외 4
- Clinical performance of the VITEK REVEAL fast antimicrobial susceptibility test within a real-world workflow for gram-negative bacteremia: comparison with QMAC-dRAST and conventional methods.
Microbiology spectrum · 2026-01 · Park J, Chung H-S, Kim M 외 4
- Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Variant Analysis in Respiratory Specimens from a Clinical Laboratory.
Public health weekly report · 2026-01 · No JS, Lee C, Kim D 외 5
- Concordance between crude extract and component allergens in a multiple allergen simultaneous test: a large-scale retrospective analysis.
British journal of biomedical science · 2026-01 · Ryu H, Park K, Kim K 외 1
- Regions of Homozygosity Identified with a Chromosomal Microarray in a Korean Population: Distribution, Frequency, and Clinical Interpretation.
Annals of laboratory medicine · 2026-01 · Kim J, Min S, Seol CA 외 1
- Significantly Decreased Progesterone Receptor Expression in Corded and Hyalinized Variant of Endometrioid Adenocarcinoma: A Potential Cause of Resistance to Progestin Treatment.
Pathobiology : journal of immunopathology, molecular and cellular biology · 2026-01 · Jo U, Park BH, Sung CO 외 1
- Germline Predisposition in Pediatric Central Nervous System Tumors: Insights from a Multigene Panel Study.
Oncology research · 2026-01 · Park M, Park S, Oh E 외 5
- Klinefelter Syndrome Identified by Next-generation Sequencing as a Risk Factor for Venous Thromboembolism: A Single-institution Study.
Annals of laboratory medicine · 2026-01 · Kim HY, Lee JJ, Park MS 외 4
- Development and Validation of a Lectin-independent Liquid Chromatography-Tandem Mass Spectrometry Method for Serum Glycosylated Alpha-fetoprotein Analysis and Comparison with a Liquid-phase Binding Assay.
Annals of laboratory medicine · 2026-01 · Kim H, Park J, Suh H 외 7
- Prognostic Significance and Functional Role of PPIB in a Retrospective Cohort of Patients with Advanced Gastric Cancer.
Oncology research · 2026-01 · Kim K, Cho E, Chung EJ 외 4
- Real-world evaluation of gnomAD variant co-occurrence information for haplotype phasing in autosomal recessive disorders.
Human genomics · 2025-12 · Kim J, Kim GH, Min S 외 2
- Comparative study of LOINC and SNOMED CT in panel mapping: enhancing interoperability in laboratory testing.
International journal of medical informatics · 2025-12 · Ryu H, Sung S, Park K 외 5
- Clinical significance of citrullinated glial fibrillary acidic protein in predicting outcomes in hepatocellular carcinoma.
World journal of gastrointestinal oncology · 2025-12 · Cho YA, Shin DW, Kim MJ 외 7
- Comparative Relatedness of Clostridioides difficile Strains Isolated from Humans and Companion Dogs in South Korea.
Antibiotics (Basel, Switzerland) · 2025-12 · Kim JY, Kwak SM, Jeong JH 외 8
- Evaluating the robustness of slide-level AI predictions on out-of-focus whole slide images: A retrospective observational study.
Journal of pathology informatics · 2025-11 · Kim HH, Ko YS, Jeong WC 외 2
- Can Reference Materials Prepared Following CLSI C37-A Be Utilized Without Commutability Assessment? Perspectives Based on Lipid Measurements.
Annals of laboratory medicine · 2025-11 · Seo JD, Kwon GC, Kim JH 외 8
- Epidemiologic Characteristics of 1.4 Million Multiplex PCR Tests for 12 Urogenital and Sexually Transmitted Infection Pathogens in Korea (2021-2024).
Pathogens (Basel, Switzerland) · 2025-10 · Shin S
- Direct Identification of IMP and VIM Metallo-β-Lactamases in Gram-Negative Bacteria Using A-MALDI.
Rapid communications in mass spectrometry : RCM · 2025-10 · Cheon DH, Hwang S, Choi YK 외 6
- A robust artificial intelligence system for predicting EBV status in gastric cancer biopsy and resection specimens.
Scientific reports · 2025-10 · Byeon K, Song B, Chae SW 외 2
- DIOR-ViT: Differential ordinal learning Vision Transformer for cancer classification in pathology images.
Medical image analysis · 2025-10 · Lee JC, Byeon K, Song B 외 2
- Development of a Multiplex Real-Time PCR Assay for the Rapid Detection of the Asian-Type DEL.
The Journal of molecular diagnostics : JMD · 2025-09 · Park MY, Lee KH, Yang YJ 외 6
- Value of the combination of intraepithelial tumor-infiltrating lymphocyte density and the heterogeneity of density as a prognostic marker in stage III colorectal cancers.
Histology and histopathology · 2025-09 · Jin HY, Jin L, Yoo SY 외 5
- Alteration of HER2 Status Following Neoadjuvant Chemotherapy in Breast Cancer: A Clinicopathological Analysis Focusing on HER2-Low Status.
Cancer research and treatment · 2025-09 · Sung HJ, Kwon HJ, Bai K 외 7
- National quality assurance program using digital cytopathology: a 5-year digital transformation experience by the Korean Society for Cytopathology.
Journal of pathology and translational medicine · 2025-09 · Chong Y, Kwon HJ, Hong SA 외 9
- Walthard Cell Nests/Transitional Cell Metaplasia in Distal Fallopian Tubes and Pelvic Peritoneum Derived From Reserve Cells.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists · 2025-09 · Jo U, Sung CO, Kim KR
- Prognostic value of signet-ring cell carcinoma proportion in undifferentiated gastric cancer: Implications for endoscopic treatment decisions.
World journal of gastroenterology · 2025-08 · Kim C, Lee HS, Na HY 외 7
- Spatial transcriptional landscape of human heart failure.
European heart journal · 2025-08 · Lee SE, Joo JH, Hwang HS 외 10
- Histologic Reaction Patterns of Lymph Node Involvement in Ovarian Serous Borderline Tumors.
Archives of pathology & laboratory medicine · 2025-07 · Kim J, Kim KR
- Artificial Intelligence-Assisted Daily Quality Control System for the Histologic Diagnosis of Gastrointestinal Endoscopic Biopsies: A 1-Year Experience.
Archives of pathology & laboratory medicine · 2025-07 · Yoo SY, Hwang Y, Yun S 외 5
- Leveraging commonality across multiple tissue slices for enhanced whole slide image classification using graph convolutional networks.
BMC medical imaging · 2025-07 · Noree S, Quinones Robles WR, Ko YS 외 1
- Shotgun Metagenomic Sequencing Analysis as a Diagnostic Strategy for Patients with Lower Respiratory Tract Infections.
Microorganisms · 2025-06 · Cho HE, Kim MJ, Choi J 외 6
- Understanding Stain Separation Improves Cross-Scanner Adenocarcinoma Segmentation with Joint Multi-Task Learning.
Studies in health technology and informatics · 2025-05 · Kim HH, Jeong WC, Park Y 외 1
- Mitochondrial myopathy revealed postoperative acute respiratory failure: A case report.
World journal of clinical cases · 2025-05 · Park SY, Hong SM, Lee HY 외 6
- Anti-liver fibrotic effects of small extracellular vesicle microRNAs from human umbilical cord-derived mesenchymal stem cells and their differentiated hepatocyte-like cells.
Biotechnology letters · 2025-04 · Choi MS, Hong JS, Lee DH 외 3
- High cellular prion protein expression in cholangiocarcinoma: A marker for early postoperative recurrence and unfavorable prognosis.
World journal of gastrointestinal surgery · 2025-03 · Shin DW, Cho YA, Moon SH 외 6
- Clinical implications of deep learning based image analysis of whole radical prostatectomy specimens.
Scientific reports · 2025-03 · Kwak TY, Lee CH, Park WY 외 10
- Evaluation of the AllplexTM stx1/2/2a/2d Typing (ASTXT) assay for the diagnosis and typing of Shiga toxin-producing Escherichia coli.
Diagnostic microbiology and infectious disease · 2025-03 · Lee HJ, Kim HJ, Choi SS 외 3
- Distinct genomic, transcriptomic, and immune profiles for tumor and non-tumor mucosal regions in early gastric cancer.
Pathology, research and practice · 2025-02 · Heo YJ, Ahn S, Kang SY 외 3
- The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers.
Journal of pathology and translational medicine · 2025-01 · Lee JA, Park HE, Jin HY 외 6
- Gaps and Similarities in Research Use LOINC Codes Utilized in Korean University Hospitals: Towards Semantic Interoperability for Patient Care.
Journal of Korean medical science · 2025-01 · Park K, Kim MS, Oh Y 외 18
- Whole genome sequencing analysis of enteropathogenic Escherichia coli from human and companion animals in Korea.
Journal of veterinary science · 2025-01 · Oh JY, Do KH, Jeong JH 외 6
- Clinical evaluation of advanced MALDI-TOF MS for carbapenemase subtyping in Gram-negative isolates.
Journal of clinical microbiology · 2025-01 · Cheon DH, Jang H, Choi YK 외 10
- Exome sequencing of 18,994 ethnically diverse patients with suspected rare Mendelian disorders.
NPJ genomic medicine · 2025-01 · Han H, Seo GH, Hyun SI 외 14
- Gintonin Binds to Reduced LPA4 Receptor Subtype in Human Cortical Neurons in Alzheimer's Disease Brains.
Biomolecules · 2025-01 · Kim KS, Lee R, Park I 외 11
- WISE: Efficient WSI selection for active learning in histopathology.
Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2024-12 · Kang H, Kim M, Ko YS 외 2
- A new quantitative real-time PCR method to measure human miRNAs using the PROMER technology.
Biochemical and biophysical research communications · 2024-12 · Nam YH, Kwak T, Kim H 외 14
- Rare primary gastric peripheral T-cell lymphoma not otherwise specified: A case report.
World journal of clinical cases · 2024-12 · Jang HR, Lee K, Lim KH
- Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer.
Breast cancer research : BCR · 2024-12 · Han E, Choi HY, Kwon HJ 외 7
- Identification of Terrisporobacter muris isolated from human blood using whole-genome sequencing: A case report.
Heliyon · 2024-10 · Kang I, Youm DJ, Kim I 외 5
- Current Developments in NK Cell Engagers for Cancer Immunotherapy: Focus on CD16A and NKp46.
Immune network · 2024-10 · Shin MH, Oh E, Minn D
- Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing.
Anticancer research · 2024-09 · Lee H, Cho YA, Kim DG 외 2
- Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases.
Brain pathology (Zurich, Switzerland) · 2024-09 · Lee B, Hwang S, Bae H 외 2
- Evaluation of a Diazo-Based Point-Of-Care Bilirubin Assay careSTART S1 Total Bilirubin Strip.
Journal of clinical laboratory analysis · 2024-08 · Kwoun W, Lee JJ, Youn YA 외 2
- Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status.
Laboratory investigation; a journal of technical methods and pathology · 2024-08 · Bai K, Woo JW, Kwon HJ 외 5
- Automatic Tumor Cellularity Measurement: AI-Based Pipeline for Multi-Organ Pathology Imaging.
Studies in health technology and informatics · 2024-08 · Ha SM, Ko YS, Park Y
- Development of a Multiplex Real-Time PCR Assay for the Simultaneous Detection of Two Fungal Pathogens Causing Pneumonia.
Journal of fungi (Basel, Switzerland) · 2024-08 · Lim HJ, Ahn S, No JH 외 6
- Author Correction: Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers.
NPJ vaccines · 2024-06 · Tan W, Thiruppathi J, Hong SH 외 13
- Artificial intelligence-based real-time histopathology of gastric cancer using confocal laser endomicroscopy.
NPJ precision oncology · 2024-06 · Cho H, Moon D, Heo SM 외 11
- Neuron type-specific optogenetic stimulation for differential stroke recovery in chronic capsular infarct.
Experimental & molecular medicine · 2024-06 · Kim RG, Cho J, Park JY 외 3
- Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers.
NPJ vaccines · 2024-06 · Tan W, Thiruppathi J, Hong SH 외 13
- Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Anticancer research · 2024-05 · Ji N, Lee Y, Lee SH 외 1
- Interpretation of PD-L1 expression in gastric cancer: summary of a consensus meeting of Korean gastrointestinal pathologists.
Journal of pathology and translational medicine · 2024-05 · Ahn S, Kwak Y, Kwon GY 외 8
- Multidrug-Resistant and Carbapenemase Gene-Carrying Acinetobacter colistiniresistens Isolated from Bloodstream Infection.
Microbial drug resistance (Larchmont, N.Y.) · 2024-05 · Chung HS, Hahm C, So MK 외 1
- Impact of Neoadjuvant Chemotherapy (NAC) on Biomarker Expression in Breast Cancer.
Medicina (Kaunas, Lithuania) · 2024-04 · Lee S, Kim JY, Lee SJ 외 9
- Clinicopathological Significance of Nucleosome Remodeling and Deacetylase Complex Expression in Endometrial Carcinoma.
Anticancer research · 2024-04 · Chu J, Lee SH, DO SI 외 1
- A Case of Asymptomatic Primary Gastric Actinomycosis Diagnosed Following Gastroscopic Biopsy.
Digestive diseases and sciences · 2024-04 · Park SH, Song CW, Kim YB 외 3
- Urinary metabolite biomarkers of pregnancy complications associated with maternal exposure to particulate matter.
Reproductive toxicology (Elmsford, N.Y.) · 2024-03 · Park S, Shim M, Lee G 외 13
- Changes in sensitization rates for respiratory and food allergens by age.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2024-03 · Choi JH, Suh JD, Kim I 외 2
- Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma.
Molecular cancer · 2024-02 · Kim J, Kim TJ, Chae S 외 21
- A predicted-loss based active learning approach for robust cancer pathology image analysis in the workplace.
BMC medical imaging · 2024-01 · Kim M, Quiñones Robles WR, Ko YS 외 3
- Dedifferentiated Leiomyosarcoma of the Uterine Corpus with Heterologous Component: Clinicopathological Analysis of Five Consecutive Cases from a Single Institution and Comprehensive Literature Review.
Diagnostics (Basel, Switzerland) · 2024-01 · Kim S, Bae H, Kim HS
- Antimicrobial Susceptibility Patterns and Genetic Diversity of Campylobacter spp. Isolates from Patients with Diarrhea in South Korea.
Microorganisms · 2024-01 · Kim SY, An D, Jeong H 외 1
- Clinicopathological and Molecular Characteristics of IDH-Wildtype Glioblastoma with FGFR3::TACC3 Fusion.
Biomedicines · 2024-01 · Bae H, Lee B, Hwang S 외 3
- Correction: Park et al. Effect of Particulate Matter 2.5 on Fetal Growth in Male and Preterm Infants through Oxidative Stress. Antioxidants 2023, 12, 1916.
Antioxidants (Basel, Switzerland) · 2024-01 · Park S, Kwon E, Lee G 외 13
- Clinicopathologic Significance of Quaking Expression in Hepatocellular Carcinoma.
In vivo (Athens, Greece) · 2024-01 · Kim SE, Park CK, Park JW 외 3
- Ovarian Metastasis from Human Papillomavirus-associated Usual-type Endocervical Adenocarcinoma: Clinicopathological Characteristics for Distinguishing from Primary Ovarian Mucinous or Endometrioid Tumor.
In vivo (Athens, Greece) · 2024-01 · Cho YA, Park CK, Kim HS
- Clinical Outcomes of Pleomorphic High-grade Squamous Intraepithelial Lesions of the Uterine Cervix: A Single-institutional Experience of 44 Cases.
In vivo (Athens, Greece) · 2024-01 · Kim H, Han B, Kim H 외 3
- Long-term trends in cycle threshold values: a comprehensive analysis of COVID-19 dynamics, viral load, and reproduction number in South Korea.
Frontiers in public health · 2024-01 · Park J, Cho SI, Kang SG 외 5
- Intratumoral 99mTc-DPD Uptake on Bone Scintigraphy in a Patient With Invasive Micropapillary Breast Carcinoma: A Pathologic Review.
Clinical nuclear medicine · 2023-12 · Koh N, Lee K, Oh HY 외 1
- Evaluation of Multiplex Rapid Antigen Tests for the Simultaneous Detection of SARS-CoV-2 and Influenza A/B Viruses.
Biomedicines · 2023-12 · Lim HJ, Lee JY, Baek YH 외 8
- The Impact of the Rapid Blood Culture Identification Panel on Antibiotic Treatment and Clinical Outcomes in Bloodstream Infections, Particularly Those Associated with Multidrug-Resistant Micro-Organisms.
Diagnostics (Basel, Switzerland) · 2023-11 · Bae JY, Bae J, So MK 외 2
- Characteristics of the Mycoplasma pneumoniae Epidemic from 2019 to 2020 in Korea: Macrolide Resistance and Co-Infection Trends.
Antibiotics (Basel, Switzerland) · 2023-11 · Shin S, Koo S, Yang YJ 외 1
- Effect of Particulate Matter 2.5 on Fetal Growth in Male and Preterm Infants through Oxidative Stress.
Antioxidants (Basel, Switzerland) · 2023-10 · Park S, Kwon E, Lee G 외 13
- Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer.
Cell reports. Medicine · 2023-10 · Kim Y, Ju H, Yoo SY 외 23
- Improving mass accuracy in matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of pathogenic proteins using 6xHIS-tagged internal calibration.
Rapid communications in mass spectrometry : RCM · 2023-10 · Lee S, Park JR, Hwang S 외 2
- A Graphene-Coated Silicon Wafer Plate Improves the Sensitivity and Reproducibility of MALDI-TOF MS Analysis of Proteins.
Journal of the American Society for Mass Spectrometry · 2023-09 · Choi YK, Cheon DH, Yang WS 외 1
- Status of Pre-analytical Quality Management of Laboratory Tests at Primary Clinics in Korea.
Annals of laboratory medicine · 2023-09 · Chang J, Lim J, Chung JW 외 3
- PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
The Journal of pathology · 2023-08 · Choi S, Kim H, Heo YJ 외 4
- Evaluation of Rapid Multiplex Reverse Transcription-Quantitative Polymerase Chain Reaction Assays for SARS-CoV-2 Detection in Individual and Pooled Samples.
Life (Basel, Switzerland) · 2023-08 · Baek YH, Park MY, Lim HJ 외 8
- A Proactive Testing Strategy to COVID-19 for Reopening University Campus during Omicron Wave in Korea: Ewha Safe Campus (ESC) Project.
Ewha medical journal · 2023-07 · Lee W, Jung-Choi K, Park H 외 8
- BRAF V600E Mutation of Non-Small Cell Lung Cancer in Korean Patients.
Medicina (Kaunas, Lithuania) · 2023-06 · Ahn HY, Lee CH, Lee MK 외 8
- Formation of aggresomes with hydrogel-like characteristics by proteasome inhibition.
Biochimica et biophysica acta. Gene regulatory mechanisms · 2023-06 · Park SH, Lee SE, Jeon JH 외 5
- Recent Advances in CAR-Based Solid Tumor Immunotherapy.
Cells · 2023-06 · Shin MH, Oh E, Kim Y 외 4
- Fast and straightforward simultaneous quantification of multiple apolipoproteins in human serum on a high-throughput LC-MS/MS platform.
Proteomics. Clinical applications · 2023-05 · Kim H, Yang WS, An D 외 2
- Comparison between Two-Dimensional and Point Shear Wave Elastography Techniques in Evaluating Liver Fibrosis Using Histological Staging as the Reference Standard: A Prospective Pilot Study.
Diagnostics (Basel, Switzerland) · 2023-05 · Lee SM, Ha HI, Lee IJ 외 9
- Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing.
Anticancer research · 2023-04 · Kim H, Kim HS
- Frequent Intraluminal Growth of Large Muscular Veins in Surgically Resected Colorectal Cancer Tissues: A 3-Dimensional Pathologic Reconstruction Study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2023-03 · Jung D, Shin J, Park J 외 11
- Clinical Evaluation of an Antigen Home Test Using Surface-Enhanced Raman Spectroscopy and Stacking Pad for SARS-CoV-2 Screening with Nasal and Salivary Swab Samples.
Diagnostics (Basel, Switzerland) · 2023-02 · Ryu H, Oh E, Cha K 외 3
- CHIP Haploinsufficiency Exacerbates Hepatic Steatosis via Enhanced TXNIP Expression and Endoplasmic Reticulum Stress Responses.
Antioxidants (Basel, Switzerland) · 2023-02 · Han JH, Nam DH, Kim SH 외 4
- HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2023-02 · Kwon CH, Seo HI, Kim DU 외 4
- Evaluation of Four Rapid Antigen Tests for the Detection of SARS-CoV-2 Infection with Nasopharyngeal Swabs.
Biomedicines · 2023-02 · Lim HJ, Park MY, Baek YH 외 11
- Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma.
Diagnostics (Basel, Switzerland) · 2023-02 · Uhm S, Cho YA, Choe JY 외 11
- Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea.
Journal of Korean medical science · 2023-02 · Song SH, Chung KY, Jee Y 외 4
- Multiple ectopic germinomas presenting as focal dystonia of fingers: a case report and literature review.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023-02 · Han S, Cho HJ, Lee BL 외 1
- Deep learning-based diagnosis of lung cancer using a nationwide respiratory cytology image set: improving accuracy and inter-observer variability.
American journal of cancer research · 2023-01 · Kim T, Chang H, Kim B 외 10
- Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study.
Cancer genomics & proteomics · 2023-01 · Cho YA, Kim SE, Park CK 외 3
- Association between Pneumonia Development and Virulence Gene Expression in Carbapenem-Resistant Acinetobacter baumannii Isolated from Clinical Specimens.
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023-01 · Bae JY, Yun I, Jun KI 외 3
- Simultaneous Quantification of Apolipoprotein C-III O-Glycoforms by Protein-MRM.
Journal of proteome research · 2023-01 · Kim H, Cheon DH, Yang WS 외 1
- Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample.
Epidemiology and health · 2023-01 · Han J, Baek HJ, Noh E 외 52
- Correction to: miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.
Breast cancer (Tokyo, Japan) · 2023-01 · Woo JW, Choi HY, Kim M 외 2
- Androgen-Independent Prostate Cancer Is Sensitive to CDC42-PAK7 Kinase Inhibition.
Biomedicines · 2022-12 · Han H, Park CK, Choi YD 외 3
- SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.
Virulence · 2022-12 · Lee JS, Yun KW, Jeong H 외 21
- Intratumoral spatial heterogeneity of tumor-infiltrating lymphocytes is a significant factor for precisely stratifying prognostic immune subgroups of microsatellite instability-high colorectal carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022-12 · Jung M, Lee JA, Yoo SY 외 3
- Clinical Performance of the Osmotic Shock-MALDI MS Method to Detect Klebsiella pneumoniae Carbapenemase in Clinical Isolates.
Journal of clinical microbiology · 2022-11 · Lee S, Hwang S, Cheon DH 외 5
- The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study.
Journal of Korean medical science · 2022-11 · Lee J, Choe YJ, Minn D 외 1
- Characteristics of BRCA2 Mutated Prostate Cancer at Presentation.
International journal of molecular sciences · 2022-11 · Han H, Park CK, Cho NH 외 5
- Evaluation of Five User-Friendly Whole Genome Sequencing Software for Mycobacterium tuberculosis in Clinical Application.
Journal of Korean medical science · 2022-11 · Kim N, Seok KH, Shin S 외 5
- Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer.
Scientific reports · 2022-11 · Han SH, Kim M, Chung YR 외 3
- Comparative Analysis of Proteomes and Phosphoproteomes in Patients with Prostate Cancer Using Different Surgical Conditions.
The world journal of men's health · 2022-10 · Ahn HS, Yeom J, Jeong H 외 9
- Optical genome mapping identifies clinically relevant genomic rearrangements in prostate cancer biopsy sample.
Cancer cell international · 2022-10 · Shim Y, Lee J, Seo J 외 7
- Characterization of Rotavirus Infection in Hospitalized Children under 5 with Acute Gastroenteritis 5 Years after Introducing the Rotavirus Vaccines in South Korea.
Children (Basel, Switzerland) · 2022-10 · Yoon HS, Sohn YH, Chae JD 외 2
- Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel.
Vaccines · 2022-10 · Kim CJ, Bae JY, Jun KI 외 7
- Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms.
Diagnostics (Basel, Switzerland) · 2022-10 · Kim HY, Han Y, Jang JH 외 3
- Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden.
Diagnostics (Basel, Switzerland) · 2022-09 · Kim H, Park S, Kang SY 외 2
- Performance Analysis of Self-Collected Nasal and Oral Swabs for Detection of SARS-CoV-2.
Diagnostics (Basel, Switzerland) · 2022-09 · Lim HJ, Baek YH, Park MY 외 7
- Assessing Resection Margin Status in Breast-conserving Surgery Specimens: Comparison Among Gross Evaluation, Frozen Section Analysis, and Permanent Section Diagnosis in 725 Patients With Breast Cancer.
Anticancer research · 2022-09 · DO J, Chu J, Ahn J 외 4
- miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.
Breast cancer (Tokyo, Japan) · 2022-09 · Woo JW, Choi HY, Kim M 외 2
- SARS-CoV-2 Infectivity and Antibody Titer Reduction for 6 Months After Second Dose of BNT162b2 mRNA Vaccine in Health Care Workers: A Prospective Cohort Study.
The Journal of infectious diseases · 2022-08 · Kim N, Shin S, Minn D 외 6
- Overexpression of FRAT1 protein is closely related to triple-negative breast cancer.
Annals of surgical treatment and research · 2022-08 · Nam SE, Ko YS, Park KS 외 8
- Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer.
BMC cancer · 2022-08 · Kim JK, Rhee YY, Bae JM 외 10
- Aeroallergen Sensitization Status in South Korea From 2018 to 2021.
Clinical and experimental otorhinolaryngology · 2022-08 · Kim I, Minn D, Kim S 외 2
- Pulmonary fibrosis model using micro-CT analyzable human PSC-derived alveolar organoids containing alveolar macrophage-like cells.
Cell biology and toxicology · 2022-08 · Choi S, Choi J, Cheon S 외 19
- Changes in the characteristics of community-onset fluoroquinolone-resistant Escherichia coli isolates causing community-acquired acute pyelonephritis in South Korea.
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2022-08 · Kim B, Kim J, Jo HU 외 14
- Comparative analysis of high- and low-level deep learning approaches in microsatellite instability prediction.
Scientific reports · 2022-07 · Park J, Chung YR, Nose A
- Cellular Prion Protein Is Closely Associated with Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma.
Diagnostics (Basel, Switzerland) · 2022-07 · Kim MJ, Cho YA, Kim E 외 8
- A carbon-black-embedded poly(dimethylsiloxane)-paper hybrid device for energy-efficient nucleic-acid amplification in point-of-care testing.
Analytical methods : advancing methods and applications · 2022-07 · Kim YL, Kim D, Park J 외 2
- Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy.
Journal of Korean medical science · 2022-06 · Park JS, Minn D, Hong S 외 4
- The Prognostic Reliability of Lymphovascular Invasion for Patients with T3N0 Colorectal Cancer in Adjuvant Chemotherapy Decision Making.
Cancers · 2022-06 · Lee H, Yoo SY, Park IJ 외 4
- Microbial byproducts determine reproductive fitness of free-living and parasitic nematodes.
Cell host & microbe · 2022-06 · Venzon M, Das R, Luciano DJ 외 7
- MixPatch: A New Method for Training Histopathology Image Classifiers.
Diagnostics (Basel, Switzerland) · 2022-06 · Park Y, Kim M, Ashraf M 외 2
- Performance evaluation of STANDARD Q COVID-19 Ag home test for the diagnosis of COVID-19 during early symptom onset.
Journal of clinical laboratory analysis · 2022-06 · Shin H, Lee S, Widyasari K 외 3
- Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers.
Journal of Korean medical science · 2022-05 · Kwon SR, Kim N, Park H 외 5
- Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020.
Medical science monitor : international medical journal of experimental and clinical research · 2022-05 · Mun KH, Jang H, Jeong H 외 8
- Comparison of Six Antifungal Susceptibilities of 11 Candida Species Using the VITEK2 AST-YS08 Card and Broth Microdilution Method.
Microbiology spectrum · 2022-04 · Lee H, Choi SH, Oh J 외 13
- Molecular epidemiological study of the G protein of human respiratory syncytial virus detected in patients with acute respiratory infections in Gyeonggi Province, South Korea.
Journal of medical virology · 2022-02 · Lee YE, Choi OK, Bang SJ 외 7
- Relationship between the appropriateness of antibiotic treatment and clinical outcomes/medical costs of patients with community-acquired acute pyelonephritis: a multicenter prospective cohort study.
BMC infectious diseases · 2022-02 · Yoon C, Park SY, Kim B 외 14
- Nutrient-specific proteomic analysis of the mucin degrading bacterium Akkermansia muciniphila.
Proteomics · 2022-02 · Lee JY, Jin HS, Kim KS 외 3
- Evaluation of Alternative Transport Media for RT-qPCR-Based SARS-CoV-2 Testing.
International journal of analytical chemistry · 2022-01 · Baek YH, Park MY, Lim HJ 외 6
- Identification of a Novel Long Non-coding RNA, lnc-ATMIN-4:2, and its Clinicopathological and Prognostic Significance in Advanced Gastric Cancer.
Cancer genomics & proteomics · 2022-01 · Kim E, Kim H, Yeo MK 외 5
- Clinicopathological and Prognostic Significance of Programmed Death Ligand-1 SP142 Expression in 132 Patients With Triple-negative Breast Cancer.
In vivo (Athens, Greece) · 2022-01 · Chu J, Yeo MK, Lee SH 외 4
- Incidence, Clinical Characteristics, and Genotype Distribution of Rotavirus in a Neonatal Intensive Care Unit 5 Years After Introducing Rotavirus Vaccine.
Frontiers in pediatrics · 2022-01 · Yoon HS, Lim J, Sohn YH 외 1
- Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea.
Epidemiology and health · 2022-01 · Yoon K, Kim J, Peck KR 외 12
- Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey.
Epidemiology and health · 2022-01 · Kim AR, Minn D, Kim SH 외 10
- Improving quality control in the routine practice for histopathological interpretation of gastrointestinal endoscopic biopsies using artificial intelligence.
PloS one · 2022-01 · Ko YS, Choi YM, Kim M 외 9
- Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.
Cancer genomics & proteomics · 2022-01 · Kim HG, Kim H, Yeo MK 외 5
- Down-regulation of TRPV6 Is Associated With Adverse Prognosis in Hepatocellular Carcinoma Treated With Curative Resection.
Cancer genomics & proteomics · 2022-01 · Koh HH, Choi S, Park CK 외 1
- Evaluation of Three Automated Extraction Systems for the Detection of SARS-CoV-2 from Clinical Respiratory Specimens.
Life (Basel, Switzerland) · 2022-01 · Lim HJ, Jung HS, Park MY 외 10
- A loss-based patch label denoising method for improving whole-slide image analysis using a convolutional neural network.
Scientific reports · 2022-01 · Ashraf M, Robles WRQ, Kim M 외 2
- Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers.
Vaccines · 2022-01 · Kim YK, Minn D, Chang SH 외 1
- Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
Journal of cancer research and clinical oncology · 2021-12 · Choi S, Lee KW, Koh HH 외 7
- Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.
Journal of Korean medical science · 2021-11 · Kim YK, Minn D, Song DY 외 6
- Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine.
Journal of Korean medical science · 2021-11 · Kang YM, Minn D, Lim J 외 6
- Optimization of a lysis method to isolate periplasmic proteins from Gram-negative bacteria for clinical mass spectrometry.
Proteomics. Clinical applications · 2021-11 · Cheon DH, Lee S, Yang WS 외 4
- Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination.
Vaccines · 2021-10 · Jo DH, Minn D, Lim J 외 4
- Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial.
ESMO open · 2021-10 · Kim JH, Kim SH, Jeon MK 외 7
- Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
Anticancer research · 2021-09 · Choi KH, Kim H, Bae GE 외 3
- Autoantibodies in moderate and critical cases of COVID-19.
Clinical and translational science · 2021-09 · Chang SH, Minn D, Kim YK
- Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.
Scientific reports · 2021-09 · Kim M, Choi HY, Woo JW 외 2
- Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
Proteomics. Clinical applications · 2021-07 · Kim KH, Lee SY, Baek JH 외 3
- Comparison of the clinical characteristics of community-acquired acute pyelonephritis between male and female patients.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2021-07 · Jang W, Jo HU, Kim B 외 14
- Increasing Trend of Nontuberculous Mycobacteria Isolation in a Referral Clinical Laboratory in South Korea.
Medicina (Kaunas, Lithuania) · 2021-07 · Lee YM, Kim MJ, Kim YJ
- Assay System for Simultaneous Detection of SARS-CoV-2 and Other Respiratory Viruses.
Diagnostics (Basel, Switzerland) · 2021-06 · Lim HJ, Park JE, Park MY 외 7
- Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer.
Scientific reports · 2021-06 · Chung YR, Woo JW, Ahn S 외 7
- Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
Journal of Korean medical science · 2021-05 · Kim N, Minn D, Park S 외 4
- Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.
Cancer immunology, immunotherapy : CII · 2021-05 · Woo JW, Chung YR, Kim M 외 3
- An Automated Microscopic Malaria Parasite Detection System Using Digital Image Analysis.
Diagnostics (Basel, Switzerland) · 2021-03 · Yoon J, Jang WS, Nam J 외 2
- Prognostic implications of PD-L1 expression in patients with angiosarcoma.
Future science OA · 2021-03 · Lee JB, Ahn BC, Kim SH 외 5
- Multilaboratory Evaluation of the MALDI-TOF Mass Spectrometry System, MicroIDSys Elite, for the Identification of Medically Important Filamentous Fungi.
Mycopathologia · 2021-03 · Lee H, Oh J, Sung GH 외 17
- Osteomyelitis Caused by Hypervirulent Klebsiella pneumoniae: The First Korean Case With Family Spread.
Annals of laboratory medicine · 2021-03 · Lee CH, Chae JD, Choe W 외 4
- Aggregation of cohorts for histopathological diagnosis with deep morphological analysis.
Scientific reports · 2021-02 · Park J, Chung YR, Kong ST 외 5
- Clinical Usefulness of LabChip Real-time PCR using Lab-On-a-Chip Technology for Diagnosing Malaria.
The Korean journal of parasitology · 2021-02 · Kim J, Lim DH, Mihn DC 외 3
- Performance Evaluation of Alere i Influenza A&B in Detecting Influenza Viruses A and B.
Annals of clinical and laboratory science · 2021-01 · Kim HN, Jang WS, Nam J 외 2
- Development of a multiplex real-time PCR assay for the simultaneous detection of four bacterial pathogens causing pneumonia.
PloS one · 2021-01 · Lim HJ, Kang ER, Park MY 외 9
- Development and evaluation of a multiplex loop-mediated isothermal amplification (LAMP) assay for differentiation of Mycobacterium tuberculosis and non-tuberculosis mycobacterium in clinical samples.
PloS one · 2021-01 · Kim J, Park BG, Lim DH 외 4
- Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea.
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2021-01 · Roh KH, Kim YK, Kim SW 외 5
- Development of an efficient Sanger sequencing-based assay for detecting SARS-CoV-2 spike mutations.
PloS one · 2021-01 · Lim HJ, Park MY, Jung HS 외 8
- Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma.
Virchows Archiv : an international journal of pathology · 2020-12 · Ha SY, Choi S, Park S 외 4
- Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020-10 · Uhm JS, Ahn JY, Hyun J 외 18
- Evolution of Interferon-Gamma Release Assay Results and Submillisievert Chest CT Findings among Close Contacts of Active Pulmonary Tuberculosis Patients.
Tuberculosis and respiratory diseases · 2020-10 · Yoon S, Mihn DC, Song JH 외 2
- Epidemiology of Congenital Bleeding Disorders: a Nationwide Population-based Korean Study.
Journal of Korean medical science · 2020-10 · Yoon HS, Han Y, Kim YJ 외 6
- Erythrocyte Alloimmunity and Genetic Variance: Results from the Collaborative Study of Alloimmunity to Antigen Diversity in Asian Populations (All ADP).
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2020-10 · Takeshita A, Watanabe H, Yamada C 외 16
- Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
Cancer research and treatment · 2020-10 · Park S, Choi S, Cho YA 외 4
- Clinical Significance of Trk Receptor Expression as a New Therapeutic Target in Hepatocellular Carcinoma.
Pathology oncology research : POR · 2020-10 · Choi S, Park S, Cho YA 외 2
- Changes in Clinical Characteristics of Community-Acquired Acute Pyelonephritis and Antimicrobial Resistance of Uropathogenic Escherichia coli in South Korea in the Past Decade.
Antibiotics (Basel, Switzerland) · 2020-09 · Kwon KT, Kim B, Ryu SY 외 13
- Clinicopathological Characteristics of Pleomorphic High-Grade Squamous Intraepithelial Lesion of the Uterine Cervix: A Single-Institutional Series of 31 Cases.
Diagnostics (Basel, Switzerland) · 2020-08 · Kim H, Choi S, Do SI 외 3
- Molecular Characteristics of GES-Type Carbapenemase-Producing Pseudomonas aeruginosa Clinical Isolates from Long-Term Care Facilities and General Hospitals in South Korea.
Microbial drug resistance (Larchmont, N.Y.) · 2020-06 · Hong JS, Choi N, Kim SJ 외 3
- Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma.
Journal of ovarian research · 2020-06 · Choi KU, Kim A, Kim JY 외 7
- A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy.
Journal of pathology and translational medicine · 2020-05 · Lee K, Jung ES, Yu E 외 10
- Continuous quality improvement program and its results of Korean Society for Cytopathology.
Journal of pathology and translational medicine · 2020-05 · Choi YD, Oh HK, Kim SJ 외 15
- Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2020-05 · Kim Y, Rhee YY, Wen X 외 4
- Biphasic Thyroid-Like Low-Grade Nasopharyngeal Papillary Adenocarcinoma with a Prominent Spindle Cell Component: A Case Report.
Diagnostics (Basel, Switzerland) · 2020-05 · Lee SH, Kim H, Kim MJ 외 2
- SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer's disease.
Scientific reports · 2020-05 · Park SA, Jung JM, Park JS 외 8
- Fatal hemolytic disease of the fetus and newborn caused by anti-Jra antibody: A case report and literature review.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2020-02 · Kim MS, Kim JS, Park H 외 6
- Placental Site Plaque of the Uterine Cervix Misinterpreted as Low-Grade Squamous Intraepithelial Lesion in Liquid-Based Cervicovaginal Cytology: Usefulness of Inhibin-α Immunocytochemistry.
Case reports in oncology · 2020-01 · Kim H, Woo HY, Lee SH 외 2
- Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma.
Cancer genomics & proteomics · 2020-01 · Cho YA, Choi S, Park S 외 2
- Hepatic Angiosarcoma: Clinicopathologic Study With an Investigation of ROS1 Gene Rearrangements.
In vivo (Athens, Greece) · 2020-01 · Jung H, Kim HN, Jang Y 외 3
- Development of a multiplex isothermal amplification molecular diagnosis method for on-site diagnosis of influenza.
PloS one · 2020-01 · Jang WS, Lim DH, Nam J 외 4
- Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA.
Oncology · 2020-01 · Jeon HM, Lee JS, Kim SH 외 11
- Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.
Cancer research and treatment · 2020-01 · Kim H, An S, Lee K 외 17
- The First Case of Para-Bombay Blood Type Encountered in a Korean Tertiary Hospital.
Journal of Korean medical science · 2019-10 · Kim MS, Kim JS, Park H 외 6
- Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma.
Scientific reports · 2019-10 · Ha SY, Yu JI, Choi C 외 7
- Common Repository of FBS Proteins (cRFP) To Be Added to a Search Database for Mass Spectrometric Analysis of Cell Secretome.
Journal of proteome research · 2019-10 · Shin J, Kwon Y, Lee S 외 33
- Mec1ATR Autophosphorylation and Ddc2ATRIP Phosphorylation Regulates DNA Damage Checkpoint Signaling.
Cell reports · 2019-07 · Memisoglu G, Lanz MC, Eapen VV 외 4
- Prognostic Role of Apelin Receptor Expression in Hepatocellular Carcinoma Treated With Curative Surgical Resection.
Anticancer research · 2019-06 · Lee T, Park CK, Ha SY
- CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma.
In vivo (Athens, Greece) · 2019-01 · Jung H, Kim HN, Jang Y 외 2
- Quantitative proteomic analysis of aqueous humor from patients with drusen and reticular pseudodrusen in age-related macular degeneration.
BMC ophthalmology · 2018-11 · Baek JH, Lim D, Park KH 외 4
- Hyalinizing Trabecular Tumor of the Thyroid Gland, a Diagnostic Challenge in Fine-Needle Aspiration Cytology: Case Report.
Journal of pathology and translational medicine · 2018-07 · Rhee YY, Jung HK, Kim SH 외 1
- Toxic Effects of Methanol among Illegally Dispatched Workers at Aluminum CNC Cutting Process in Small-Scale, Third-Tier Subcontractor Factories of Smartphone Manufacturers in the Republic of Korea.
International journal of environmental research and public health · 2018-06 · Kang CW, Kim H, Shin K 외 4
- Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival.
Virchows Archiv : an international journal of pathology · 2018-05 · Kim JY, Lee SH, An S 외 6
- Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression.
Clinical endoscopy · 2018-05 · Ahn YH, Rhee YY, Choi SC 외 1
- Merkel Cell Carcinoma Metastatic to Pleural Fluid: A Case Report.
Journal of pathology and translational medicine · 2018-05 · Rhee YY, Kim SH, Kim EK 외 1
- Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
BMC cancer · 2018-02 · Cho YJ, Kim SH, Kim EK 외 14
- The effect of long working hours on cerebrovascular and cardiovascular disease; A case-crossover study.
American journal of industrial medicine · 2017-09 · Shin KS, Chung YK, Kwon YJ 외 2
- Association of Foxp3 Polymorphism With Allograft Outcome in Kidney Transplantation.
Annals of laboratory medicine · 2017-09 · Park H, Lee N, In JW 외 5
- The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists.
Journal of pathology and translational medicine · 2017-07 · Kim M, Park HJ, Min HS 외 17
- Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
Oncogene · 2017-06 · Kim HS, Jung M, Kang HN 외 14
- Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma.
Oncotarget · 2017-05 · Kim SH, Kim SH, Yang WI 외 2
- Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
Annals of laboratory medicine · 2017-05 · Park HS, Choi J, See CJ 외 6
- Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.
International journal of molecular sciences · 2017-04 · Ko YS, Hwang TS, Kim JY 외 6
- Report on the Project for Establishment of the Standardized Korean Laboratory Terminology Database, 2015.
Journal of Korean medical science · 2017-04 · Jung BK, Kim J, Cho CH 외 11
- Formaldehyde and carbon dioxide air concentrations and their relationship with indoor environmental factors in daycare centers.
Journal of the Air & Waste Management Association (1995) · 2017-03 · Hwang SH, Lee GB, Kim IS 외 1
- Molecular Testing for Gastrointestinal Cancer.
Journal of pathology and translational medicine · 2017-03 · Lee HS, Kim WH, Kwak Y 외 15
- Calibration of High-Density Lipoprotein Cholesterol Values From the Korea National Health and Nutrition Examination Survey Data, 2008 to 2015.
Annals of laboratory medicine · 2017-01 · Yun YM, Song J, Ji M 외 8
- Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.
Journal of Korean medical science · 2016-12 · Cho HK, Lee H, Kim HW 외 4
- Effect of daily chlorhexidine bathing on the acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit with methicillin-resistant S aureus endemicity.
American journal of infection control · 2016-12 · Kim JS, Chung YK, Lee SS 외 7
- HLA-A, HLA-B and HLA-DRB1 allele and haplotype frequencies of 10 918 Koreans from bone marrow donor registry in Korea.
International journal of immunogenetics · 2016-10 · Park H, Lee YJ, Song EY 외 1
- A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma.
Cold Spring Harbor molecular case studies · 2016-09 · Chen KS, Kwon WS, Kim J 외 8
- Long Non-coding RNA HOTAIR Expression in Diffuse Large B-Cell Lymphoma: In Relation to Polycomb Repressive Complex Pathway Proteins and H3K27 Trimethylation.
Journal of pathology and translational medicine · 2016-09 · Oh EJ, Kim SH, Yang WI 외 2
- The Diagnostic Utility of the Point-of-Care CYP2C19 Genotyping Assay in Patients with Acute Coronary Syndrome Dosing Clopidogrel: Comparison with Platelet Function Test and SNP Genotyping.
Annals of clinical and laboratory science · 2016-09 · Choi JL, Kim BR, Woo KS 외 4
- Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
BMC cancer · 2016-07 · Kim C, Kim EK, Jung H 외 15
- Multiple Human Papillomavirus Infection Is Associated with High-Risk Infection in Male Genital Warts in Ulsan, Korea.
Journal of Korean medical science · 2016-03 · Kwon T, Moon KH, Yang SH 외 6
- Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea.
Archives of pathology & laboratory medicine · 2016-03 · Jung S, Lee B, Lee KN 외 2
- Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas.
Journal of pathology and translational medicine · 2016-03 · Kim EK, Yoon SO, Kim SH 외 3
- In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.
Annals of laboratory medicine · 2016-03 · Lee H, Roh KH, Hong SG 외 6
- Qualitative content analysis of psychologic discomfort and coping process after needlestick injuries among health care workers.
American journal of infection control · 2016-02 · Jeong JS, Son HM, Jeong IS 외 6
- The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016-02 · Kim SH, Yang WI, Min YH 외 2
- Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents.
Journal of Korean medical science · 2016-01 · Yoon SH, Kim HW, Ahn JG 외 4
- Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial Infection.
PloS one · 2016-01 · Park JY, Park S, Lee SH 외 12
- Decreased concentration of serum melatonin in nighttime compared with daytime female medical technologists in South Korea.
Chronobiology international · 2016-01 · Song G, Yoon KA, Chi H 외 2
- IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production.
Oncotarget · 2015-12 · Kim MS, Kang JW, Jeon JS 외 4
- Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories.
Annals of laboratory medicine · 2015-11 · Hong SK, Choi SJ, Shin S 외 13
- Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity.
American journal of infection control · 2015-11 · Chung YK, Kim JS, Lee SS 외 7
- Reduction in oxidative stress biomarkers after adenotonsillectomy.
International journal of pediatric otorhinolaryngology · 2015-09 · Cho JH, Suh JD, Kim YW 외 3
- Comparative evaluation of two matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems, Vitek MS and Microflex LT, for the identification of Gram-positive cocci routinely isolated in clinical microbiology laboratories.
Journal of microbiological methods · 2015-06 · Lee M, Chung HS, Moon HW 외 2
- The impact of HLA and KIR ligand mismatching on unrelated allogeneic hematopoietic stem cell transplantation in Korean adult patients.
Annals of laboratory medicine · 2015-01 · Park H, Rho EY, In JW 외 6
- Decline in non-smoking workers' urine cotinine levels after increased smoking regulation in Korea.
Annals of occupational and environmental medicine · 2015-01 · Park JH, Lee CK, Kim SY 외 8
- Comparison of the Xpert MTB/RIF Assay and Real-time PCR for the Detection of Mycobacterium tuberculosis.
Annals of clinical and laboratory science · 2015-01 · Kim MJ, Nam YS, Cho SY 외 2
- Single-channel multiplexing without melting curve analysis in real-time PCR.
Scientific reports · 2014-12 · Lee YJ, Kim D, Lee K 외 1
- Epidemiological aspects of pertussis among adults and adolescents in a Korean outpatient setting: a multicenter, PCR-based study.
Journal of Korean medical science · 2014-09 · Park S, Lee SH, Seo KH 외 16
- Evaluation of an immunochromatographic assay for the rapid and simultaneous detection of rotavirus and adenovirus in stool samples.
Annals of laboratory medicine · 2014-05 · Kim J, Kim HS, Kim HS 외 7
- Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2014-04 · Kwon MJ, Roh KH, Park H 외 1
- Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.
Journal of virological methods · 2008-04 · Kim JK, Lee HJ, Lee YJ 외 7
- Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene.
Nucleic acids research · 2007-01 · Chun JY, Kim KJ, Hwang IT 외 4
- Heat shock protein 25 or inducible heat shock protein 70 activates heat shock factor 1: dephosphorylation on serine 307 through inhibition of ERK1/2 phosphorylation.
The Journal of biological chemistry · 2006-06 · Seo HR, Chung DY, Lee YJ 외 7
- Annealing control primer system for identification of differentially expressed genes on agarose gels.
BioTechniques · 2004-03 · Kim YJ, Kwak CI, Gu YY 외 2
- Annealing control primer system for improving specificity of PCR amplification.
BioTechniques · 2003-12 · Hwang IT, Kim YJ, Kim SH 외 3
Patents
KIPRIS · applicant-matchedUS · Published · 2026-03 · Application 19577458
US · Published · 2026-01 · Application 19461807
US · Published · 2026-01 · Application 19451321
US · Published · 2025-12 · Application 19404105
PCT · Published · 2025-09 · Application PCT/KR2025/014941
PCT · Published · 2025-06 · Application PCT/KR2025/009247
PCT · Published · 2025-06 · Application PCT/KR2025/009082
PCT · Published · 2025-06 · Application PCT/KR2025/008138
PCT · Published · 2025-04 · Application PCT/KR2025/004761
Published · 2025-04 · Application 1020267026206
Show 401 more patents
US · Published · 2025-03 · Application 19085214
Published · 2025-03 · Application 1020267027614
Published · 2025-02 · Application 1020267027613
Published · 2025-02 · Application 1020267027611
Published · 2025-02 · Application 1020267025048
Published · 2025-01 · Application 1020267024280
Published · 2024-12 · Application 1020240200359
Published · 2024-12 · Application 1020267017316
Published · 2024-12 · Application 1020267008627
Published · 2024-12 · Application 1020267015410
PCT · Published · 2024-12 · Application PCT/KR2024/097149
Published · 2024-12 · Application 1020267018578
Published · 2024-12 · Application 1020267015409
Published · 2024-11 · Application 1020267017084
PCT · Published · 2024-11 · Application PCT/KR2024/018906
Published · 2024-11 · Application 1020267008637
Published · 2024-11 · Application 1020267017017
Published · 2024-11 · Application 1020267018576
Published · 2024-10 · Application 1020240146989
Published · 2024-10 · Application 1020240146988
PCT · Published · 2024-10 · Application PCT/KR2024/015945
Published · 2024-10 · Application 1020240144419
Published · 2024-10 · Application 1020240144420
EP · Published · 2024-09 · Application 24873000.4
Published · 2024-09 · Application 1020267008498
Published · 2024-09 · Application 1020240123777
Published · 2024-09 · Application 1020267001953
Published · 2024-07 · Application 1020267001611
PCT · Published · 2024-07 · Application PCT/KR2024/010509
Published · 2024-07 · Application 1020267001519
Published · 2024-07 · Application 1020267002166
Published · 2024-07 · Application 1020267003631
Published · 2024-06 · Application 1020257037824
Published · 2024-06 · Application 1020257041465
PCT · Published · 2024-06 · Application PCT/KR2024/007542
Published · 2024-06 · Application 1020257038849
US · Published · 2024-05 · Application 18662065
Published · 2024-04 · Application 1020257030948
Published · 2024-04 · Application 1020240056967
Published · 2024-04 · Application 1020257030547
Published · 2024-04 · Application 1020257029781
Published · 2024-03 · Application 1020240041807
Published · 2024-03 · Application 1020240039622
Published · 2024-03 · Application 1020240039623
Published · 2024-03 · Application 1020240039627
Published · 2024-03 · Application 1020240039626
Published · 2024-03 · Application 1020240039625
Published · 2024-03 · Application 1020240039624
Published · 2024-03 · Application 1020257031776
Published · 2024-03 · Application 1020240034537
CN · Published · 2024-02 · Application 202480015282.4
Published · 2024-02 · Application 1020257020733
Published · 2024-02 · Application 1020257021307
Published · 2024-01 · Application 1020257026945
Published · 2024-01 · Application 1020240009435
Published · 2023-12 · Application 1020257022576
Published · 2023-12 · Application 1020257010182
Published · 2023-12 · Application 1020230187760
Published · 2023-12 · Application 1020257022227
Published · 2023-12 · Application 1020257018632
Published · 2023-12 · Application 1020257018902
Published · 2023-11 · Application 1020230169000
Registered · 2023-11 · Application 1020230170018
Published · 2023-11 · Application 1020257017192
US · Published · 2023-11 · Application 19129378
Published · 2023-11 · Application 1020257015162
Registered · 2023-11 · Application 1020230155460
US · Published · 2023-11 · Application 18386762
US · Published · 2023-11 · Application 18386759
Published · 2023-10 · Application 1020257011818
Registered · 2023-10 · Application 1020230146074
Registered · 2023-10 · Application 1020230146073
Registered · 2023-10 · Application 1020230146072
Registered · 2023-10 · Application 1020230143789
Published · 2023-10 · Application 1020257013860
Published · 2023-10 · Application 1020230142294
Published · 2023-10 · Application 1020257006886
Published · 2023-10 · Application 1020257010671
Published · 2023-10 · Application 1020257015367
Published · 2023-10 · Application 1020230134663
Published · 2023-09 · Application 1020257011102
Published · 2023-09 · Application 1020230127603
CN · Published · 2023-09 · Application 202380085731.8
PCT · Published · 2023-09 · Application PCT/KR2023/013113
Published · 2023-09 · Application 1020257022226
Published · 2023-08 · Application 1020257006275
US · Published · 2023-08 · Application 19105620
Published · 2023-08 · Application 1020257000555
Published · 2023-07 · Application 1020257003345
Published · 2023-07 · Application 1020257003044
Registered · 2023-07 · Application 1020257000245
Withdrawn · 2023-06 · Application 1020230084592
Published · 2023-06 · Application 1020257002487
Published · 2023-06 · Application 1020247042902
Published · 2023-06 · Application 1020247043555
Published · 2023-05 · Application 1020247039030
Published · 2023-05 · Application 1020247037414
US · Published · 2023-05 · Application 18864964
US · Published · 2023-05 · Application 18863100
EP · Published · 2023-05 · Application 23803766.7
PCT · Published · 2023-05 · Application PCT/KR2023/006141
Withdrawn · 2023-05 · Application 1020247037934
Published · 2023-04 · Application 1020247043529
US · Published · 2023-04 · Application 18860242
EP · Published · 2023-04 · Application 23788646.0
PCT · Published · 2023-04 · Application PCT/KR2023/005092
Published · 2023-04 · Application 1020247034227
Published · 2023-04 · Application 1020247036047
Published · 2023-04 · Application 1020247036185
Published · 2023-04 · Application 1020247036184
Registered · 2023-03 · Application 1020230037784
Published · 2023-03 · Application 1020247030371
Published · 2023-02 · Application 1020247028240
US · Published · 2023-02 · Application 18170308
Published · 2023-02 · Application 1020247026474
US · Published · 2023-02 · Application 18836696
Published · 2023-02 · Application 1020247029945
Published · 2023-01 · Application 1020230010895
US · Published · 2023-01 · Application 18833018
EP · Published · 2023-01 · Application 23747284.0
Rejected · 2023-01 · Application 1020247024912
EP · Published · 2022-12 · Application 22919080.6
PCT · Published · 2022-12 · Application PCT/KR2022/021237
Published · 2022-12 · Application 1020247019530
Published · 2022-12 · Application 1020247020762
US · Published · 2022-12 · Application 18722984
Published · 2022-12 · Application 1020247024235
US · Published · 2022-12 · Application 18717748
Published · 2022-12 · Application 1020247018680
Published · 2022-12 · Application 1020220170784
Rejected · 2022-11 · Application 1020247009825
Published · 2022-11 · Application 1020220144779
Published · 2022-10 · Application 1020247011825
US · Published · 2022-10 · Application 18697069
EP · Published · 2022-10 · Application 22887590.2
PCT · Published · 2022-10 · Application PCT/KR2022/016432
Published · 2022-10 · Application 1020247012332
Published · 2022-10 · Application 1020247014239
Published · 2022-10 · Application 1020247016153
US · Published · 2022-09 · Application 18692623
EP · Published · 2022-09 · Application 22870362.5
PCT · Published · 2022-09 · Application PCT/KR2022/013921
Published · 2022-09 · Application 1020247008859
Published · 2022-09 · Application 1020247012331
Published · 2022-09 · Application 1020247011123
Published · 2022-08 · Application 1020220106293
Published · 2022-08 · Application 1020247005798
Published · 2022-08 · Application 1020220099332
Published · 2022-07 · Application 1020220093042
Registered · 2022-07 · Application 1020237037070
Published · 2022-07 · Application 1020220090885
Published · 2022-07 · Application 1020247005974
Published · 2022-07 · Application 1020247002510
Published · 2022-06 · Application 1020247012330
Published · 2022-06 · Application 1020247002511
CN · Published · 2022-06 · Application 202280042896.2
US · Published · 2022-06 · Application 18570381
Published · 2022-06 · Application 1020247000843
Withdrawn · 2022-05 · Application 1020220056175
Withdrawn · 2022-05 · Application 1020220056174
Withdrawn · 2022-05 · Application 1020220056176
Withdrawn · 2022-05 · Application 1020220056173
Registered · 2022-05 · Application 1020237040145
Registered · 2022-05 · Application 1020237038463
Published · 2022-04 · Application 1020220053239
Withdrawn · 2022-04 · Application 1020220051994
Published · 2022-04 · Application 1020237039949
Published · 2022-03 · Application 1020237028288
US · Published · 2022-03 · Application 18277020
EP · Registered · 2022-03 · Application 22763658.6
PCT · Published · 2022-03 · Application PCT/KR2022/003219
Registered · 2022-03 · Application 1020237025219
PCT · Published · 2022-02 · Application PCT/KR2022/001948
Published · 2022-02 · Application 1020237023624
Published · 2022-01 · Application 1020237028279
Published · 2021-12 · Application 1020237025830
Registered · 2021-12 · Application 1020237016262
Published · 2021-12 · Application 1020237020326
Registered · 2021-12 · Application 1020237021344
Registered · 2021-12 · Application 1020237018132
Published · 2021-11 · Application 1020237017273
Registered · 2021-11 · Application 1020237017280
Registered · 2021-11 · Application 1020237009021
Rejected · 2021-10 · Application 1020237008374
Published · 2021-10 · Application 1020237012369
Withdrawn · 2021-09 · Application 1020210129800
Registered · 2021-09 · Application 1020237011819
Registered · 2021-09 · Application 1020237004568
Rejected · 2021-09 · Application 1020237006334
CN · Published · 2021-08 · Application 202180052974.2
Registered · 2021-08 · Application 1020237005040
Published · 2021-08 · Application 1020237005039
US · Published · 2021-08 · Application 18023105
PCT · Published · 2021-08 · Application PCT/KR2021/011556
Registered · 2021-08 · Application 1020237007982
Registered · 2021-07 · Application 1020237004267
Registered · 2021-07 · Application 1020237004270
Registered · 2021-07 · Application 1020237000129
Registered · 2021-07 · Application 1020210097688
US · Published · 2021-07 · Application 18014645
EP · Registered · 2021-07 · Application 21843383.7
PCT · Published · 2021-07 · Application PCT/KR2021/009055
Rejected · 2021-07 · Application 1020237000652
Published · 2021-06 · Application 1020227045143
Published · 2021-06 · Application 1020237000651
US · Published · 2021-06 · Application 18011678
PCT · Published · 2021-06 · Application PCT/KR2021/007762
Rejected · 2021-06 · Application 1020237000480
EP · Published · 2021-06 · Application 21816989.4
PCT · Published · 2021-06 · Application PCT/KR2021/007011
Rejected · 2021-06 · Application 1020227042383
Registered · 2021-03 · Application 1020227037035
Registered · 2021-03 · Application 1020227032449
Published · 2021-03 · Application 1020267001495
US · Published · 2021-03 · Application 17911906
PCT · Published · 2021-03 · Application PCT/KR2021/003137
Published · 2021-03 · Application 1020227031474
Registered · 2020-12 · Application 1020227024212
Registered · 2020-11 · Application 1020227011005
Registered · 2020-11 · Application 1020227018390
CN · Published · 2020-06 · Application 202080042081.5
Registered · 2020-06 · Application 1020217040232
Registered · 2020-05 · Application 1020217042113
Published · 2020-05 · Application 1020257029610
Registered · 2020-05 · Application 1020217042916
Registered · 2020-03 · Application 1020217026312
Registered · 2020-03 · Application 1020247009289
Registered · 2020-02 · Application 1020217030444
Registered · 2019-12 · Application 1020217022246
Withdrawn · 2019-11 · Application 1020190157540
PCT · Published · 2019-06 · Application PCT/KR2019/007908
Registered · 2019-06 · Application 1020217002499
Registered · 2019-06 · Application 1020217001803
US · Registered · 2019-04 · Application 17049075
PCT · Published · 2019-04 · Application PCT/KR2019/005227
Registered · 2019-04 · Application 1020207034516
CN · Published · 2019-04 · Application 201980027488.8
US · Registered · 2019-04 · Application 17043198
EP · Registered · 2019-04 · Application 19787805.1
PCT · Published · 2019-04 · Application PCT/KR2019/004780
Registered · 2019-04 · Application 1020207033618
Withdrawn · 2019-03 · Application 1020190030641
Withdrawn · 2019-02 · Application 1020190022831
Registered · 2018-12 · Application 1020207022623
Registered · 2018-12 · Application 1020180156437
CN · Published · 2018-09 · Application 201880062947.1
US · Registered · 2018-09 · Application 16650052
EP · Published · 2018-09 · Application 24210201.0
EP · Registered · 2018-09 · Application 18863356.4
PCT · Published · 2018-09 · Application PCT/KR2018/011559
Registered · 2018-09 · Application 1020207010373
Registered · 2018-09 · Application 1020207009820
Registered · 2018-08 · Application 1020207009412
Registered · 2018-08 · Application 1020207005706
Registered · 2018-08 · Application 1020207011629
CN · Published · 2018-07 · Application 201880049116.0
Registered · 2018-07 · Application 1020207002308
Registered · 2018-06 · Application 1020197035672
US · Published · 2018-05 · Application 17054233
PCT · Published · 2018-05 · Application PCT/KR2018/005338
Registered · 2018-05 · Application 1020207035683
EP · Registered · 2018-04 · Application 18788341.8
Registered · 2018-04 · Application 1020197032056
CN · Published · 2018-03 · Application 201880021950.9
Registered · 2018-03 · Application 1020217019554
Registered · 2018-03 · Application 1020197031943
US · Registered · 2018-01 · Application 15865554
CN · Published · 2017-12 · Application 201780081416.2
EP · Registered · 2017-12 · Application 17886256.1
Registered · 2017-12 · Application 1020197022318
Registered · 2017-12 · Application 1020217022054
Registered · 2017-12 · Application 1020227017356
Registered · 2017-12 · Application 1020237015908
Registered · 2017-09 · Application 1020197012818
Registered · 2017-06 · Application 1020207018598
Registered · 2017-06 · Application 1020197000487
Registered · 2017-06 · Application 1020207018597
Withdrawn · 2017-06 · Application 1020170076906
EP · Registered · 2017-06 · Application 17810581.3
Registered · 2017-06 · Application 1020197000236
CN · Published · 2017-06 · Application 201780048113.0
Registered · 2017-06 · Application 1020197000224
Registered · 2017-06 · Application 1020197000113
Registered · 2017-06 · Application 1020217036681
Registered · 2017-05 · Application 1020197036134
Registered · 2017-05 · Application 1020187035977
Registered · 2017-03 · Application 1020187031711
Registered · 2017-02 · Application 1020187025800
Registered · 2017-01 · Application 1020187024671
CN · Published · 2016-12 · Application 201680073310.3
Registered · 2016-12 · Application 1020187020434
CN · Published · 2016-11 · Application 201680067863.8
Registered · 2016-11 · Application 1020187017559
Registered · 2016-09 · Application 1020187008454
US · Registered · 2016-02 · Application 15550292
PCT · Published · 2016-02 · Application PCT/KR2016/001436
Registered · 2016-02 · Application 1020177024741
CN · Published · 2015-12 · Application 201580067067.X
CN · Published · 2015-12 · Application 201580071592.9
EP · Registered · 2015-12 · Application 15867540.5
Registered · 2015-12 · Application 1020177018994
Registered · 2015-12 · Application 1020177018993
Registered · 2015-12 · Application 1020197025679
EP · Registered · 2015-09 · Application 15847004.7
Registered · 2015-09 · Application 1020177011966
Withdrawn · 2015-04 · Application 1020150051080
CN · Published · 2014-12 · Application 201480077317.3
CN · Published · 2014-12 · Application 201910807436.4
CN · Published · 2014-12 · Application 202511759692.2
CN · Published · 2014-12 · Application 202511759638.8
CN · Published · 2014-12 · Application 202010806475.5
Registered · 2014-12 · Application 1020227034325
Registered · 2014-12 · Application 1020167029473
Registered · 2014-12 · Application 1020187007421
Registered · 2014-12 · Application 1020217002697
Registered · 2014-12 · Application 1020227003377
Registered · 2014-12 · Application 1020197034833
CN · Published · 2014-10 · Application 201480057117.1
EP · Registered · 2014-10 · Application 14854330.9
Registered · 2014-10 · Application 1020167011243
EP · Registered · 2014-07 · Application 14831476.8
Registered · 2014-07 · Application 1020167001717
Registered · 2014-07 · Application 1020167000802
EP · Registered · 2014-05 · Application 14791659.7
EP · Registered · 2014-03 · Application 14762484.5
Registered · 2014-03 · Application 1020157023027
CN · Published · 2014-02 · Application 201480030498
Registered · 2014-02 · Application 1020157032356
EP · Registered · 2014-02 · Application 14156323.9
CN · Published · 2013-12 · Application 201380068241
EP · Registered · 2013-12 · Application 13868457.6
Registered · 2013-12 · Application 1020157017974
US · Registered · 2013-12 · Application 14095403
EP · Registered · 2013-04 · Application 13777882.5
Registered · 2013-04 · Application 1020147027748
CN · Published · 2013-02 · Application 201380021365
EP · Registered · 2013-02 · Application 13757737.5
Registered · 2013-02 · Application 1020147024658
CN · Published · 2012-07 · Application 201280071069
EP · Registered · 2012-07 · Application 12867064.3
Registered · 2012-07 · Application 1020147022148
EP · Registered · 2012-05 · Application 12779532.6
Registered · 2012-05 · Application 1020137029140
Registered · 2012-03 · Application 1020137026012
Withdrawn · 2012-03 · Application 1020120028429
Withdrawn · 2012-02 · Application 1020120013302
CN · Published · 2012-01 · Application 201280001703
CN · Published · 2012-01 · Application 201410132450
EP · Registered · 2012-01 · Application 19169021.3
EP · Registered · 2012-01 · Application 16205399.5
EP · Registered · 2012-01 · Application 14186326.6
EP · Registered · 2012-01 · Application 13196447.0
Registered · 2012-01 · Application 1020127027068
Registered · 2011-10 · Application 1020137010497
Withdrawn · 2011-03 · Application 1020110023465
Withdrawn · 2011-01 · Application 1020110002840
Registered · 2010-12 · Application 1020157025690
Withdrawn · 2010-12 · Application 1020137007096
Withdrawn · 2010-10 · Application 1020100103599
CN · Published · 2010-09 · Application 201080047406
CN · Published · 2010-09 · Application 201610146451.5
Registered · 2010-09 · Application 1020127007442
Expired · 2010-04 · Application 1020127010543
Registered · 2010-03 · Application 1020127017999
Registered · 2010-03 · Application 1020127019048
Registered · 2009-11 · Application 1020127014773
Withdrawn · 2009-11 · Application 1020090107262
Withdrawn · 2009-11 · Application 1020090105428
Withdrawn · 2009-10 · Application 1020090097861
Rejected · 2008-10 · Application 1020080107008
Withdrawn · 2008-07 · Application 1020080073642
Withdrawn · 2007-12 · Application 1020070134955
Rejected · 2007-10 · Application 1020070104185
PCT · Published · 2007-09 · Application PCT/KR2007/004452
PCT · Published · 2007-05 · Application PCT/KR2007/002458
Registered · 2007-03 · Application 1020070024849
Rejected · 2006-10 · Application 1020060103745
Withdrawn · 2006-07 · Application 1020060062388
Expired · 2006-05 · Application 1020087027939
Expired · 2006-03 · Application 1020077022882
Expired · 2006-03 · Application 1020137023486
Expired · 2006-03 · Application 1020147010516
Expired · 2006-03 · Application 1020117025255
Expired · 2006-03 · Application 1020097015358
EP · Registered · 2006-03 · Application 11168429.6
EP · Registered · 2006-03 · Application 06716196.8
PCT · Published · 2006-03 · Application PCT/KR2006/000746
Withdrawn · 2006-03 · Application 1020137001209
Withdrawn · 2006-03 · Application 1020107017077
Expired · 2006-02 · Application 1020060017503
Withdrawn · 2005-11 · Application 1020050110670
Withdrawn · 2005-11 · Application 1020050104023
PCT · Published · 2005-04 · Application PCT/KR2005/001206
Expired · 2003-11 · Application 1020067011506
Expired · 2002-11 · Application 1020047008678
EP · Registered · 2002-09 · Application 02765682.6
PCT · Published · 2002-09 · Application PCT/KR2002/001781
Expired · 2002-09 · Application 1020047008441
PCT · Published · 2002-05 · Application PCT/KR2002/000816
PCT · Published · 2001-12 · Application PCT/KR2001/002133
Rejected · 2001-02 · Application 1020010006636
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive1
- OpenAIOAI-SearchBot66
- GoogleGoogleOther23
- PerplexityPerplexityBot3
- AnthropicClaudeBot2
Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for SEEGENE, INC. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.
Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Founded 2011, KOSDAQ-listed 2020, Gencurix develops liquid-biopsy diagnostics: breast cancer prognosis and lung/colorectal companion tests.
Founded in 1999 and listed on KOSDAQ in 2011, iNtRON Biotechnology develops bacteriophage-based new drugs via its itLysin and IMPA platforms alongside a molecular diagnostics business.
Cancer molecular diagnostics company behind the EarlyTect-C stool-based colorectal cancer test using the SDC2 methylation biomarker.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition